Metal and Plastic Biliary Stents to Drain Malignant Distal Biliary Strictures.
PROTESIED
1 other identifier
observational
871
1 country
1
Brief Summary
Multicentric Italian registry aimed to evaluated the role and results of plastic and metal stents in the treatment of malignant distal biliary strictures
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFirst Submitted
Initial submission to the registry
February 25, 2023
CompletedFirst Posted
Study publicly available on registry
March 9, 2023
CompletedNovember 13, 2024
November 1, 2024
2.6 years
February 25, 2023
November 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the potency of biliary stents (plastic and metal)
Time to occurrence of jaundice/cholangitis
through study completion, an average of 1 year
Interventions
Endoscopic placement of plastic and metal biliary stents
Eligibility Criteria
Patients requiring for the first time drainage of malignant distal biliary stricture
You may qualify if:
- Malignant distal biliary stricture
- Need for Palliative and pre-operative biliary drainage
- Age \> 18
- Signature of the informed consent
You may not qualify if:
- Previous endoscopic/radiological biliary drainage
- Stricture close to the main hepatic confluence(\< 2 cm)
- Duodenal stenosis
- Post- surgical altered anatomy
- Benign disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Policlinico Gemelli IRCCS
Roma, 00168, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Tringali, MD, PhD
Fondazione Policlinico Gemelli IRCCS, Rome, Italy
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assitant Professor
Study Record Dates
First Submitted
February 25, 2023
First Posted
March 9, 2023
Study Start
January 7, 2020
Primary Completion
July 31, 2022
Study Completion
December 31, 2022
Last Updated
November 13, 2024
Record last verified: 2024-11